Adient (ADNT)
15.13
0.54 (3.70%)
At close: Mar 26, 2025, 3:59 PM
14.75
-2.52%
After-hours: Mar 26, 2025, 08:00 PM EDT
Adient Revenue Breakdown
Quarter | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2016 |
---|---|---|---|---|---|
Seating Segment Revenue | 3.74B | 3.75B | 4.03B | 4.13B | 4.04B |
Seating Segment Revenue Growth | -0.29% | -6.90% | -2.54% | +2.33% | n/a |
Seating, Seat Structures and Mechanisms Revenue | 420M | 705M | 783M | 797M | n/a |
Seating, Seat Structures and Mechanisms Revenue Growth | -40.43% | -9.96% | -1.76% | n/a | n/a |
Revenue by Geography
Quarter | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2019 | Sep 30, 2018 |
---|---|---|---|---|---|
Americas Revenue | 6.76B | 7.22B | 6.56B | 7.79B | 1.46B |
Americas Revenue Growth | -6.33% | +10.11% | -15.77% | +431.76% | n/a |
Asia Revenue | 2.99B | 3.08B | 2.93B | 2.34B | 1.18B |
Asia Revenue Growth | -3.11% | +5.43% | +25.20% | +98.56% | n/a |
China Revenue | 1.42B | 1.39B | 1.37B | 529M | 3.16B |
China Revenue Growth | +2.53% | +0.80% | +159.74% | -83.26% | n/a |
Czechia Revenue | 756M | 900M | 962M | 6.67B | 6.12B |
Czechia Revenue Growth | -16.00% | -6.44% | -85.59% | +9.10% | n/a |
Emea Revenue | 5.03B | 5.2B | 4.76B | 1.46B | n/a |
Emea Revenue Growth | -3.20% | +9.05% | +225.63% | n/a | n/a |
Germany Revenue | 942M | 1.05B | 862M | 529M | n/a |
Germany Revenue Growth | -9.94% | +21.35% | +62.95% | n/a | n/a |
Japan Revenue | 344M | 373M | 264M | 2.71B | n/a |
Japan Revenue Growth | -7.77% | +41.29% | -90.25% | n/a | n/a |
Korea, Republic Of Revenue | 488M | 534M | 2.43B | 435M | n/a |
Korea, Republic Of Revenue Growth | -8.61% | -78.00% | +457.93% | n/a | n/a |
Mexico Revenue | 2.63B | 2.66B | 377M | 614M | n/a |
Mexico Revenue Growth | -1.01% | +605.84% | -38.60% | n/a | n/a |
Other Asia Revenue | 294M | 338M | 508M | 6.43B | n/a |
Other Asia Revenue Growth | -13.02% | -33.46% | -92.11% | n/a | n/a |
Other Emea Revenue | 3.74B | 963M | 5.88B | n/a | n/a |
Other Emea Revenue Growth | +287.95% | -83.61% | n/a | n/a | n/a |
Other Non-Us Revenue | 314M | 564M | n/a | n/a | n/a |
Other Non-Us Revenue Growth | -44.33% | n/a | n/a | n/a | n/a |
Poland Revenue | 939M | 6.53B | n/a | n/a | n/a |
Poland Revenue Growth | -85.62% | n/a | n/a | n/a | n/a |
Thailand Revenue | 496M | n/a | n/a | n/a | n/a |
Thailand Revenue Growth | n/a | n/a | n/a | n/a | n/a |
United States Revenue | 5.89B | n/a | n/a | n/a | n/a |
United States Revenue Growth | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 126M | 140M | 117M | 113M | 149M | 148M | 149M | 141M | 138M | 159M | 142M | 135M | 162M | 88M | 136M | 148M | 149M | 170M | 115M | 127M | 163M | 160M | 165M | 168M | 176M | 133M | 177M | 188M | 196M | 127M | 169M | 178M | 217M | 402M | 315M | 252M | 253M | 225M | 299M | 298M |
Selling, General, and Administrative Revenue Growth | -10.00% | +19.66% | +3.54% | -24.16% | +0.68% | -0.67% | +5.67% | +2.17% | -13.21% | +11.97% | +5.19% | -16.67% | +84.09% | -35.29% | -8.11% | -0.67% | -12.35% | +47.83% | -9.45% | -22.09% | +1.88% | -3.03% | -1.79% | -4.55% | +32.33% | -24.86% | -5.85% | -4.08% | +54.33% | -24.85% | -5.06% | -17.97% | -46.02% | +27.62% | +25.00% | -0.40% | +12.44% | -24.75% | +0.34% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | 362M | n/a | n/a | n/a | 322M | n/a | n/a | n/a | 316M | n/a | n/a | n/a | 370M | n/a | n/a | n/a | 454M | n/a | n/a | n/a | 513M | n/a | n/a | n/a | 488M | n/a | n/a | n/a | 460M | n/a | n/a | n/a | 599M | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a |